New test to assess ovarian cancer

March 9, 2010 2:35:31 PM PST
A new kind of test may help doctors tell if an ovarian mass is cancerous or benign.

The test is called OVA1 and will be sold by Quest Diagnostics. It allows physicians to assess, before surgery, the likelihood that a woman's mass is malignant. The company says that knowledge could help doctors direct a women to a specialist more quickly.

Ovarian cancer is the leading cause of death from gynecologic cancer in the United States.

It is estimated more than 1 million women will be diagnosed with an ovarian mass this year.